← Evidence map

ArticleCritical care (London, England)2020

The use of a neuromuscular blocking agent could significantly decrease mortality in moderate-to-severe ARDS patients: is moderate ARDS the best indication for neuromuscular blocking agents.

Patrick M Honore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

The use of a neuromuscular blocking agent could significantly decrease mortality in moderate-to-severe ARDS patients: is moderate ARDS the best indication for neuromuscular blocking agents. | OpenQuestion